Scotia Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.62M Buy
15,093
+104
+0.7% +$11.2K 0.01% 451
2025
Q1
$1.51M Sell
14,989
-805
-5% -$81.2K 0.01% 443
2024
Q4
$1.41M Buy
15,794
+34
+0.2% +$3.04K 0.01% 458
2024
Q3
$1.32M Sell
15,760
-22
-0.1% -$1.84K 0.01% 457
2024
Q2
$1.22M Buy
15,782
+9
+0.1% +$693 0.01% 462
2024
Q1
$1.08M Sell
15,773
-1,248
-7% -$85.5K 0.01% 482
2023
Q4
$984K Buy
17,021
+7,014
+70% +$405K 0.01% 455
2023
Q3
$528K Sell
10,007
-13
-0.1% -$686 ﹤0.01% 550
2023
Q2
$542K Hold
10,020
﹤0.01% 541
2023
Q1
$501K Sell
10,020
-1,405
-12% -$70.3K ﹤0.01% 545
2022
Q4
$529K Sell
11,425
-4,335
-28% -$201K ﹤0.01% 549
2022
Q3
$610K Buy
15,760
+1,295
+9% +$50.1K ﹤0.01% 527
2022
Q2
$539K Sell
14,465
-820
-5% -$30.6K ﹤0.01% 559
2022
Q1
$677K Buy
15,285
+4,183
+38% +$185K ﹤0.01% 575
2021
Q4
$472K Sell
11,102
-50
-0.4% -$2.13K ﹤0.01% 636
2021
Q3
$484K Sell
11,152
-8,515
-43% -$370K ﹤0.01% 621
2021
Q2
$841K Hold
19,667
0.01% 534
2021
Q1
$760K Buy
19,667
+4,118
+26% +$159K 0.01% 531
2020
Q4
$559K Buy
15,549
+4,531
+41% +$163K 0.01% 541
2020
Q3
$421K Buy
+11,018
New +$421K ﹤0.01% 529
2020
Q1
Sell
-23,811
Closed -$1.08M 650
2019
Q4
$1.08M Sell
23,811
-31,396
-57% -$1.42M 0.01% 382
2019
Q3
$2.25M Buy
55,207
+4,930
+10% +$201K 0.03% 263
2019
Q2
$2.16M Buy
50,277
+38,470
+326% +$1.65M 0.03% 275
2019
Q1
$453K Buy
11,807
+4,567
+63% +$175K 0.01% 519
2018
Q4
$256K Buy
7,240
+300
+4% +$10.6K ﹤0.01% 566
2018
Q3
$267K Buy
+6,940
New +$267K ﹤0.01% 627